JithmaPrasadAbeykoonMD

Physician

Dr. Abeykoon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
University of Kansas School of MedicineClass of 2015

PubMed

Central nervous system crystal-storing histiocytosis: A case report and literature review.
Nabeela Nathoo, Daniel P Larson, Yong Guo, Caterina Giannini, Claudia F Lucchinetti
European Journal of Neurology. 2025-01-01
Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder.
Polyzois Makras, Dana Erickson, Caroline J Davidge-Pitts, Eli L Diamond, Carl E Allen
The Journal of Clinical Endocrinology and Metabolism. 2024-12-19
Low magnesium levels and prognosis in newly diagnosed diffuse large B-cell lymphoma.
Jennifer J Gile, Matthew Maurer, Gordon J Ruan, Jithma P Abeykoon, Joy R Heimgartner
The Oncologist. 2024-12-06

Journal Articles

Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia
Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis
Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature

Abstracts/Posters

Molecular Alterations in Adult Histiocytic Neoplasms
Jithma P. Abeykoon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
Jithma P. Abeykoon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
Jithma P. Abeykoon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Outcomes with rituximab plus bendamustine (R-Benda), dexamethasone, rituximab, cyclophosphamide (DRC), and bortezomib, dexamethasone, rituximab (BDR) as primary therap...
2019 ASCO Annual Meeting - 6/1/2019